Clinical Trial Update: Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children [Phase 3]

View source ↗

Summary

Phase III clinical trial evaluating pegylated somatropin for growth hormone deficiency in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED